Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Using CAD-EYE for detecting cancer lesions in Lynch syndrome patients

Official title: Evaluation of the CAD-EYE System for the Detection of Colorectal Neoplastic Lesions in Patients With Lynch Syndrome

Run by French Society of Digestive Endoscopy · NCT05963191 · Data updated 2026-11-12

This study tests if using the CAD-EYE system during colonoscopies can help find cancer lesions better in people with Lynch syndrome compared to regular methods.

More Lynch Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment272 (estimated)
SponsorFrench Society of Digestive Endoscopy
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedApril 18, 2024
Main results expectedApril 18, 2025
Study endsApril 18, 2026
Registry record updatedSeptember 3, 2025
Trial IDNCT05963191 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with confirmed pathogenic mutations associated with Lynch syndrome.

Probably not a fit

Patients who have undergone total colectomy or have a history of inflammatory bowel disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of the CAD-EYE system in enhancing the detection of neoplastic lesions during colorectal cancer screening in patients with Lynch syndrome. Lynch syndrome significantly increases the risk of colorectal cancer, making effective screening crucial. The study aims to compare the adenoma detection rate using CAD-EYE colonoscopy versus traditional methods. Participants will undergo colonoscopy with the CAD-EYE system to evaluate its potential benefits in improving cancer detection rates.

Why it matters

Potential benefit: If successful, this approach could lead to earlier and more accurate detection of colorectal cancer in patients with Lynch syndrome.

How similar studies have gone: While the use of artificial intelligence in colonoscopy is emerging, this specific application of CAD-EYE in Lynch syndrome patients is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed pathogenic mutation (path\_MLH1, path\_MSH2, path\_MSH6, path\_PMS2, path\_EpCAM)
* Male or female of legal age at time of colonoscopy prescription.
* Patient agreeing to participate in the study
* Person affiliated with or benefiting from a social security scheme
* Free, informed and express consent

Exclusion Criteria:

* Patient undergoing total colectomy with ileoanal or ileosigmoid anastomosis
* Patient with a history of Crohn's disease or ulcerative colitis
* Patients with a known allergy or intolerance to polyethylene glycol and ascorbic acid.
* Patients unable to undergo fractionated colonic preparation
* Inadequate colonic preparation: Boston sub-score \<2 per segment
* Patient under guardianship or protected person
* Patient who does not understand French or cannot read
* Person not affiliated to a Social Security system.
* Pregnant women

Where it's running

  • Hôpital Européen Georges-Pompidou HEGP
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.